Mobile App

Google Play Apple Store
Conversations in Oncology: Updates in the Treatment of Graft Versus Host Disease
Certified CME/CNE Activity
This certified CME/CNE activity features a recorded discussion among three experts reviewing new therapies and protocols to improve outcomes in (Graft Versus Host Disease) GVHD.

This educational activity will focus on the new therapies and protocols to improve outcomes in GVHD. Data will be reviewed and analyzed by expert faculty while discussing common patient scenarios and best practices in treatment.
Review each video to claim AMA or ANCC credit/contact hour(s) after completion of the brief Post-Test/Evaluations.




James L. M. Ferrara, MD, DSc James L. M. Ferrara, MD, DSc
Ward-Coleman Chair in Cancer Medicine
Professor of Medicine and Pediatrics
Director, Hematologic Malignancies Translational Research Center,
Icahn School of Medicine at Mount Sinai
Mark A. Schroeder, MD Mark A. Schroeder, MD
Associate Professor of Medicine,
Washington University School of Medicine,
Division of Oncology,
Section of Stem Cell Transplantation
       
Celalettin Ustun, MD Celalettin Ustun, MD
Professor, Department of Internal Medicine,
Division of Hematology, Oncology and Cell Therapy,
Section of Bone Marrow Transplantation and Cellular Therapy Rush Medical College,
Section Chief, Bone Marrow and Stem Cell Transplant
   

20

Supported by an independent educational grant from Incyte Corporation


Launch Date: March 16, 2021

Release Date: March 16, 2021

Expiration Date: February 28, 2022

February 28, 2022
Mini Module
6961
GVHD_WebBanner(1150px).gif
Hematology-Oncology